Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GRAL NASDAQ:PODD NASDAQ:TMDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRALGRAIL$71.13-2.3%$41.25$12.57▼$75.53$2.62B4.111.04 million shs1.08 million shsPODDInsulet$320.38+1.5%$323.15$226.50▼$353.50$22.21B1.4662,831 shs567,335 shsTMDXTransMedics Group$112.98-4.3%$117.48$55.00▼$145.50$4.02B2.08881,470 shs1.17 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRALGRAIL-2.28%+9.89%+89.53%+74.64%+450.12%PODDInsulet+1.55%+2.62%-9.19%+10.74%+38.19%TMDXTransMedics Group-4.30%-2.66%+4.34%+0.46%-17.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRALGRAIL$71.13-2.3%$41.25$12.57▼$75.53$2.62B4.111.04 million shs1.08 million shsPODDInsulet$320.38+1.5%$323.15$226.50▼$353.50$22.21B1.4662,831 shs567,335 shsTMDXTransMedics Group$112.98-4.3%$117.48$55.00▼$145.50$4.02B2.08881,470 shs1.17 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRALGRAIL-2.28%+9.89%+89.53%+74.64%+450.12%PODDInsulet+1.55%+2.62%-9.19%+10.74%+38.19%TMDXTransMedics Group-4.30%-2.66%+4.34%+0.46%-17.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRALGRAIL 2.00Hold$56.67-20.33% DownsidePODDInsulet 2.85Moderate Buy$346.838.26% UpsideTMDXTransMedics Group 2.50Moderate Buy$125.4010.99% UpsideCurrent Analyst Ratings BreakdownLatest GRAL, TMDX, and PODD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025GRALGRAILWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025PODDInsuletWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/8/2025TMDXTransMedics GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/6/2025TMDXTransMedics GroupZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold10/3/2025GRALGRAILUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$75.0010/3/2025GRALGRAILCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$43.00 ➝ $75.0010/3/2025PODDInsuletRothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$350.00 ➝ $370.0010/1/2025PODDInsuletThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$399.00 ➝ $375.009/29/2025PODDInsuletCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$353.00 ➝ $399.009/29/2025TMDXTransMedics GroupZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy9/27/2025GRALGRAILWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRALGRAIL$125.60M20.42$28.23 per share2.52$74.50 per share0.95PODDInsulet$2.07B10.89$4.51 per share71.11$17.27 per share18.55TMDXTransMedics Group$441.54M8.72$1.57 per share71.75$6.81 per share16.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRALGRAIL-$2.03B-$13.11N/AN/AN/A-329.86%-16.64%-14.02%11/11/2025 (Estimated)PODDInsulet$418.30M$3.2997.3864.462.6210.01%23.78%9.30%11/6/2025 (Estimated)TMDXTransMedics Group$35.46M$1.9358.5479.01N/A13.49%28.02%8.64%10/27/2025 (Estimated)Latest GRAL, TMDX, and PODD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025PODDInsulet$1.15N/AN/AN/A$678.70 millionN/A10/27/2025Q3 2025TMDXTransMedics Group$0.37N/AN/AN/A$145.33 millionN/A8/12/2025Q2 2025GRALGRAIL-$3.14-$3.18-$0.04-$3.18$37.57 million$35.54 million8/7/2025Q2 2025PODDInsulet$0.92$1.17+$0.25$0.32$612.31 million$649.10 million7/30/2025Q2 2025TMDXTransMedics Group$0.48$0.92+$0.44$0.92$146.64 million$157.37 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGRALGRAILN/AN/AN/AN/AN/APODDInsuletN/AN/AN/AN/AN/ATMDXTransMedics GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRALGRAILN/A9.239.23PODDInsulet0.642.261.81TMDXTransMedics Group1.619.869.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRALGRAILN/APODDInsuletN/ATMDXTransMedics Group99.67%Insider OwnershipCompanyInsider OwnershipGRALGRAIL1.85%PODDInsulet0.39%TMDXTransMedics Group7.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRALGRAIL1,36036.05 million35.38 millionOptionablePODDInsulet3,90070.39 million70.12 millionOptionableTMDXTransMedics Group21034.09 million31.70 millionOptionableGRAL, TMDX, and PODD HeadlinesRecent News About These CompaniesTransMedics Group, Inc. $TMDX Shares Acquired by Valmark Advisers Inc.2 hours ago | marketbeat.comWeiss Ratings Reaffirms Hold (C) Rating for TransMedics Group (NASDAQ:TMDX)5 hours ago | marketbeat.comThere's Been No Shortage Of Growth Recently For TransMedics Group's (NASDAQ:TMDX) Returns On CapitalOctober 9 at 6:59 PM | uk.finance.yahoo.comStocks Showing Improved Relative Strength: TransMedics GroupOctober 9 at 5:08 AM | msn.comTransMedics Group (NASDAQ:TMDX) Rating Lowered to Hold at Zacks ResearchOctober 8 at 7:32 AM | marketbeat.comGlobal Assets Advisory LLC Sells 12,550 Shares of TransMedics Group, Inc. $TMDXOctober 7 at 4:35 AM | marketbeat.comTransMedics Group Acquires Aircraft for Organ TransportOctober 6, 2025 | msn.comGC Wealth Management RIA LLC Makes New Investment in TransMedics Group, Inc. $TMDXOctober 2, 2025 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Raised to "Strong-Buy" at Zacks ResearchOctober 2, 2025 | americanbankingnews.comTransMedics Group (NASDAQ:TMDX) Upgraded by Zacks Research to Strong-Buy RatingOctober 1, 2025 | marketbeat.comPark Avenue Securities LLC Invests $445,000 in TransMedics Group, Inc. $TMDXSeptember 30, 2025 | marketbeat.comTaylor Frigon Capital Management LLC Trims Stock Position in TransMedics Group, Inc. $TMDXSeptember 29, 2025 | marketbeat.comTransMedics, Mercedes-Benz partner on organ transportation across ItalySeptember 26, 2025 | msn.comVoya Investment Management LLC Sells 2,890 Shares of TransMedics Group, Inc. $TMDXSeptember 26, 2025 | marketbeat.comIf You Invested $100 In TransMedics Group Stock 5 Years Ago, You Would Have This Much TodaySeptember 25, 2025 | benzinga.comTMDX Partners With Mercedes-Benz to Launch Organ Transport NetworkSeptember 25, 2025 | zacks.comTransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 25, 2025 | marketbeat.comHere's Why TransMedics (TMDX) is a Strong Growth StockSeptember 24, 2025 | zacks.comSilver Oak Securities Incorporated Purchases 2,823 Shares of TransMedics Group, Inc. $TMDXSeptember 23, 2025 | marketbeat.comTransMedics teams with Mercedes-Benz Group on organ transportation across ItalySeptember 22, 2025 | msn.comTransMedics, Mercedes team up on ground transportation network for organ transplants in ItalySeptember 22, 2025 | massdevice.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGRAL, TMDX, and PODD Company DescriptionsGRAIL NASDAQ:GRAL$71.13 -1.66 (-2.28%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$72.73 +1.60 (+2.25%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.Insulet NASDAQ:PODD$320.38 +4.89 (+1.55%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$320.50 +0.13 (+0.04%) As of 10/9/2025 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.TransMedics Group NASDAQ:TMDX$112.98 -5.08 (-4.30%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$113.00 +0.02 (+0.02%) As of 05:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
